Pay in 4 interest-free payments of $5.99 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
The statements regarding oxidative treatments have not been evaluated by the FDA.
Jake Lombardo, Co-founder and CEO, Anodyne Nanotech, presented the preclinical data on the once-weekly GLP-1 patch at the 14th annual Partnerships in Drug Delivery (PODD2024) Conference in 2024
Weight Loss A highly desired benefit of GLP-1 receptor agonists, such as Wegovy, is their effectiveness in promoting weight loss
Duality has supported more than 25 startups, helped raise over $50 million in follow-on funding, and developed a growing network of corporate, academic, and investor partners since it launched in 2021
US$ 29.26
US$ 29.67
US$ 21.83
US$ 26.70
US$ 27.73
